Security key
00808Y406
Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD)
CUSIP: 00808Y406
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 51,941
- Total 13F value
- $113,749
- Share change
- +51,941
- SEC-reported price per share
- $2.19
- Number of holders
- 10
- Value change
- +$113,749
- Number of buys
- 10
- Shares outstanding
- 1,651,503
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
10
Top holders
10
AEMD full security history
Ownership snapshot
Full 13F holder table
AETHLON MEDICAL INC SEC filings
AETHLON MEDICAL INC company facts
Broader feeds
Ownership snapshot
Top reported holders of AEMD - Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Sabrina Martucci Johnson
Disclosed value leader
Sabrina Martucci Johnson
Comparable rows
0/6
Latest evidence
01 Feb 2023
3/4/5
Highest disclosed value: $73,676
6 rows are not safely comparable across share classes.
Quick read
Sabrina Martucci Johnson has the largest disclosed position value at $73.7K.
0 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Sabrina Martucci Johnson's linked filing trail.
Disclosed position value
Top 1
Sabrina Martucci Johnson
$73.7K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 6 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Sabrina Martucci Johnson |
3/4/5
Director
|
—
class O/S missing
|
$73,676
33,642 shares
|
— | 31 Mar 2022 |
| Charles J. Fisher Jr. |
3/4/5
Chief Executive Officer, Director
|
—
class O/S missing
|
—
192,600 shares
|
— | 10 Feb 2022 |
| Guy F. Cipriani |
3/4/5
Sr. V.P., Chief Bus. Officer, Director
|
—
class O/S missing
|
—
100,200 shares
|
— | 10 Feb 2022 |
| James B. Frakes |
3/4/5
CFO & Sr. VP ? Finance
|
—
class O/S missing
|
—
100,200 shares
|
— | 10 Feb 2022 |
| Steven P. Larosa |
3/4/5
Chief Medical Officer
|
—
class O/S missing
|
—
100,200 shares
|
— | 10 Feb 2022 |
| Lee D. Arnold |
3/4/5
Chief Scientific Officer
|
—
class O/S missing
|
—
60,620 shares
|
— | 01 Feb 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
51,941
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
0
Q4 2023 holders
10
Holder diff
10
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|